Pashayan syndrome

From WikiMD's WELLNESSPEDIA

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Pashayan syndrome
Synonyms
Pronounce
Specialty Medical genetics
Symptoms Craniosynostosis, hypertelorism, maxillary hypoplasia, brachydactyly, syndactyly
Complications N/A
Onset
Duration
Types
Causes Genetic mutation
Risks
Diagnosis Clinical diagnosis, genetic testing
Differential diagnosis
Prevention
Treatment Surgical intervention
Medication
Prognosis
Frequency Rare
Deaths


Pashayan syndrome is a rare genetic disorder characterized by a combination of physical abnormalities and developmental delays. The syndrome was first described by Dr. Haroutune Krikor Pashayan in the late 20th century.

Clinical Features[edit]

Individuals with Pashayan syndrome typically present with a variety of clinical features, which may include:

Genetics[edit]

Pashayan syndrome is believed to follow an autosomal recessive inheritance pattern. This means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. The specific gene or genes involved in Pashayan syndrome have not yet been identified.

Diagnosis[edit]

The diagnosis of Pashayan syndrome is primarily based on clinical evaluation and the presence of characteristic features. Genetic testing may be used to confirm the diagnosis and to differentiate it from other similar syndromes.

Management[edit]

There is no cure for Pashayan syndrome, and treatment is primarily supportive and symptomatic. Management may include:

Prognosis[edit]

The prognosis for individuals with Pashayan syndrome varies depending on the severity of the symptoms and the presence of associated medical conditions. Early intervention and supportive care can improve the quality of life for affected individuals.

See Also[edit]

See also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.